ESSA Pharma (EPIX) Expected to Announce Earnings on Monday

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) is expected to post its Q3 2025 quarterly earnings results before the market opens on Monday, August 4th. Analysts expect ESSA Pharma to post earnings of ($0.24) per share for the quarter.

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. On average, analysts expect ESSA Pharma to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ESSA Pharma Price Performance

Shares of NASDAQ EPIX opened at $1.88 on Friday. ESSA Pharma has a twelve month low of $1.40 and a twelve month high of $7.88. The firm has a market cap of $83.45 million, a P/E ratio of -2.98 and a beta of 1.55. The company has a 50 day moving average of $1.76 and a 200 day moving average of $1.70.

About ESSA Pharma

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.